Veery Capital, LLC Pfizer Inc Transaction History

Veery Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$39.39 - $51.28 $2,875 - $3,743	73 Added 1.47%	5,024 $204,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $2,045 - $2,670	-49 Reduced 0.98%	4,951 $0
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $218 - $267	5 Added 0.1%	5,000 $219,000
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $18,286 - $21,681	-393 Reduced 7.29%	4,995 $262,000
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $16,195 - $20,068	354 Added 7.03%	5,388 $279,000
Q4 2021 Jan 13, 2022	BUY	$41.32 - $61.25 $3,057 - $4,532	74 Added 1.49%	5,034 $297,000
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $194,680 - $250,083	4,960 New	4,960 $213,000

3,271

3.63B

74.3M

107M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Veery Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Veery Capital, LLC with notifications on news.